# 68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

> **NCT06155318** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 300 (estimated)

## Conditions studied

- Gastroenteropancreatic Neuroendocrine Tumor

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included

## Key facts

- **NCT ID:** NCT06155318
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-05
- **Primary completion:** 2029-05-05
- **Final completion:** 2029-05-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06155318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06155318, "68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06155318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*